Biotech companies have always licensed programs, but never so many from one region in particular.

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to ...

Insider got exclusive access to bankruptcy-risk ratings to identify vulnerable biotechs. The biotech market has dropped 42% this year, putting cash-starved or debt-laden firms at risk. The firm ...

Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Leading figures from artificial intelligence, biotechnology, and national security are urging governments to mandate ...

Jonathan Faison first started exploring the biotech space a decade ago. He emphasizes a focus on preserving capital by limiting position sizes and picking stocks that have multiple "irons in the fire" ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...